Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.02 +0.25 (+13.84%)
At close: Oct 20, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Revenue (2021 - 2024)

Updated

Analysis

Acumen Pharmaceuticals (ABOS) Revenue (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Acumen Pharmaceuticals 147.03 Mn -335.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 3.01 Mn
Sep 30, 2023 3.12 Mn
Jun 30, 2023 1.88 Mn
Mar 31, 2023 1.83 Mn
Dec 31, 2022 1.39 Mn
Sep 30, 2022 663,000.00
Jun 30, 2022 260,000.00
Mar 31, 2022 76,000.00
Dec 31, 2021 62,000.00
Sep 30, 2021 14,000.00
Jun 30, 2021 4,000.00
Mar 31, 2021 4,000.00
API Access

Acumen Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ABOS&period=max&api_key=YOUR_API_KEY